drugset / Trial / NCT06465992

Liposomal Bupivacaine With Dexamethasone for Foot Surgery

NCT06465992 ↗

Phase 4 Unknown 126 enrolled Rothman Institute Orthopaedics
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to understand the ideal formulation to utilize in saphenous nerve and popliteal nerve blocks for foot and ankle procedures. It will examine the use of liposomal bupivacaine alone or liposomal bupivacaine with dexamethasone prior to foot and ankle procedures in peripheral nerve blocks. We will compare liposomal bupivacaine (Exparel) and liposomal bupivacaine (Exparel) combined with dexamethasone to determine if the addition of dexamethasone significantly decreases postoperative narcotic use and prolongs analgesic effects when administered in a popliteal and saphenous block prior to foot and ankle orthopedic procedures.

Timeline

Start
2024-06-17
Primary completion
2025-06-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 266 mg Other
Comparator Dexamethasone Small molecule 10 mg Other
Comparator Bupivacaine Other / unclassified 10 ml Other

Indications

No indication recorded.